Bladder Cancer Clinical Trial

Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay

Summary

The AnchorDx UriFind™ Bladder Cancer Assay is designed to detect 2 DNA methylation biomarkers in urine specimens from patients 22 years or older suspected of having bladder cancer. Results from the assay are intended for use, in conjunction with current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Clinical Validation Group:

22 years or older, gender is not limited
Suspected of bladder cancer (including hematuria, inflammatory bladder, suspicious ultrasound results)
Can receive standard of care, including urine cytology, cystoscopy, or surgery for bladder cancer diagnosis
Can provide at least of 100 ml of urine (prior to cystoscopy or surgery)

The assay specificity samples (some samples can overlap with non-cancer cases of the clinical validation group):

Healthy volunteers
Genitourinary benign diseases
Genitourinary cancer (non-bladder)
Non-Genitourinary benign diseases
Non-Genitourinary cancer

Exclusion Criteria:

1) History of urinary cancer 2) Neoadjuvant therapy

-

Study is for people with:

Bladder Cancer

Estimated Enrollment:

1100

Study ID:

NCT05643690

Recruitment Status:

Recruiting

Sponsor:

PPsanalytics

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Arkansas Urology
Little Rock Arkansas, 72211, United States More Info
Katie O'Brien
Contact
Idaho Urologic Institute
Meridian Idaho, 83642, United States More Info
Stephanie Luckie
Contact

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

1100

Study ID:

NCT05643690

Recruitment Status:

Recruiting

Sponsor:


PPsanalytics

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.